Downstream Processing Featured Articles

  1. Forsyth Scientists Define The Bacteria That Live In The Mouth, Throat, And Gut 9/20/2012

    For the first time, scientists have defined the bacteria that inhabit multiple sites along the healthy human digestive tract in a large number of individuals. To prevent and control bacterial diseases, it is essential to first identify which bacteria are responsible for keeping us in good health.

  2. International Stem Cell Corporation Demonstrates Positive Animal Efficacy Results In Metabolic Liver Disease Program 2/12/2013

    International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company") a California-based biotechnology company, today announced the conclusions from its study demonstrating the efficacy and safety of the hepatocyte-like cells (HLC) derived from human parthenogenetic stem cells (hpSC) in a well-established animal model of a congenital liver disorder associated with bilirubin metabolism.

  3. Additional Details Concerning Issue Of Shares To Johnson & Johnson Development Corporation As Part Of The Daratumumab Agreement 8/30/2012

    Genmab A/S announced recently additional details concerning the subscription of shares by Johnson & Johnson Development Corporation (JJDC) as part of the global license and development agreement for daratumumab (HuMax-CD38) between Genmab (see Genmab's Company Announcement 20) and Janssen Biotech, Inc., one of the Janssen Pharmaceutical companies of Johnson & Johnson.

  4. LEWA Uses A Globally Exclusive License To HPLC Technology From Bayer Technology Services 6/12/2012

    Bayer Technology Services (BTS) is a well-known supplier of industrial chromatography products and services in the area of process technologies for the Bayer Group and for external customers. 

  5. Boehringer Ingelheim Implements Flexible Fully Disposable Up- And Downstream Manufacturing For Biopharmaceuticals 9/10/2012

    Boehringer Ingelheim has developed and now implemented a flexible set-up and operational approach for disposable technologies within its global biopharmaceutical development and manufacturing network.

  6. Aeras Signs Agreement With GSK To Jointly Advance TB Vaccine 10/10/2012

    Aeras announces that it has signed an agreement with GlaxoSmithKline Vaccines, S.A. (GSK) to jointly advance the clinical development of an investigational tuberculosis (TB) vaccine containing GSK’s proprietary M72 antigen and AS01E adjuvant.

  7. Caliper's 'Lab On A Chip' Technology To Screen Neurocrine Assays 1/21/1999
    Caliper Technologies Corp. and Neurocrine Biosciences, Inc. are combining their drug discovery efforts to develop treatments for central nervous system and immune system diseases...
  8. COTI-2 Found To Correct Specific p53 Gene Mutation In Human Ovarian Cancer Cells 12/13/2012

    Critical Outcome Technologies Inc. (COTI) (TSX VENTURE:COT) released important new test results today proving that COTI-2, the company's lead oncology candidate, stops cancer cells from replicating by correcting the effects of specific genetic errors affecting the p53 gene.

  9. AdvantaPure®'s BioPharm Tubing And Single-Use Systems To Be Featured At Upcoming Fall Shows 9/9/2010
    High purity tubing manufacturer AdvantaPure will exhibit at three trade shows for the pharmaceutical and bioprocess industries this fall. Each exhibition will provide the company with opportunities to meet with customers and prospects, answer questions, and promote the continuing adoption of single use products.
  10. Avid Bioservices Announces Completion Of Facility Upgrades In Response To Increased Demand For Its Contract Manufacturing Services 12/13/2012

    Avid Bioservices, Inc, a contract manufacturing organization (CMO) focused on the process development and manufacturing of monoclonal antibodies, proteins and enzymes, today announced that its demand for services has reached an all-time high, while projected revenue for its current fiscal year ending April 2013 is expected to surpass $18 million, a 20% increase from the previous fiscal year.